Conmed (CNMD) Change in Receivables (2010 - 2026)
Conmed (CNMD) posted Change in Receivables of -$18.6 million for Q1 2026, down 182.07% on a QoQ basis from $22.7 million in Q4 2025, and up 1.99% year-over-year from -$18.2 million in Q1 2025.
Conmed (CNMD) Change in Receivables (2010 - 2026) Analysis & Trends
Conmed's Change in Receivables history runs 17 years deep, the most recent figure standing at -$18.6 million for Q1 2026.
- Quarterly Change in Receivables rose 1.99% year-over-year to -$18.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.7 million (up 114.99% YoY) and the FY2025 annual result came in at $2.4 million, up 45.83% from the prior year.
- Change in Receivables was -$18.6 million for Q1 2026 at Conmed, down from $22.7 million in the prior quarter.
- Across five years, Change in Receivables topped out at $22.7 million in Q4 2025 and bottomed at -$19.0 million in Q1 2025.
- A 5-year average of $2.2 million and a median of $908000.0 in 2024 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2023 — Change in Receivables soared 12578.53% — and 2025, when it sank 2190.75%.
- Conmed's Change in Receivables stood at -$10.9 million in 2022, then soared by 183.14% to $9.1 million in 2023, then surged by 36.97% to $12.4 million in 2024, then soared by 82.83% to $22.7 million in 2025, then sank by 182.07% to -$18.6 million in 2026.
- Business Quant data shows CNMD's Change in Receivables at -$18.6 million in Q1 2026, $22.7 million in Q4 2025, and -$9.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.16 Bn | 176.87 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 128.86 Bn | 125.98 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 108.89 Bn | 99.67 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 47.44 Bn | 43.76 Bn | 1.29 Bn | 117.90 Mn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.16 Bn | 1.98 Bn | -141.00 Mn |
| 7 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn | -124.60 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn | - |
| 10 | Conmed | 1.34 Bn | 1.30 Bn | 183.45 Mn | -18.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.61 Mn |
| Mar 31, 2026 | -18.61 Mn |
| Dec 31, 2025 | 22.67 Mn |
| Dec 31, 2025 | 22.67 Mn |
| Sep 30, 2025 | -9.16 Mn |
| Sep 30, 2025 | -9.16 Mn |
| Jun 30, 2025 | 7.84 Mn |
| Jun 30, 2025 | 7.84 Mn |
| Mar 31, 2025 | -18.98 Mn |
| Mar 31, 2025 | -18.98 Mn |
| Dec 31, 2024 | 12.40 Mn |
| Dec 31, 2024 | 12.40 Mn |
| Sep 30, 2024 | -10.78 Mn |
| Sep 30, 2024 | -10.78 Mn |
| Jun 30, 2024 | -914,000.00 |
| Jun 30, 2024 | -914,000.00 |
| Mar 31, 2024 | 908,000.00 |
| Mar 31, 2024 | 908,000.00 |
| Dec 31, 2023 | 9.05 Mn |
| Dec 31, 2023 | 9.05 Mn |